Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
- Status
- UNKNOWN
- Phase
- NA
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
- Status
- UNKNOWN
- Phase
- PHASE2
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Patient-derived Glioma Stem Cell Organoids
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
- Status
- UNKNOWN
- Phase
- NA
Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE3
ASP8374 + Cemiplimab in Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
- Status
- COMPLETED
- Phase
- N/A
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Glioblastoma Response Prediction to Apatinib
- Status
- COMPLETED
- Phase
- N/A
SurVaxM Expanded Access Protocol
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2